Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12613000697785
Ethics application status
Approved
Date submitted
20/06/2013
Date registered
26/06/2013
Date last updated
26/06/2013
Type of registration
Prospectively registered

Titles & IDs
Public title
Measuring the benefit of buccal oxygenation in the apnoeic patient
Scientific title
Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of buccal RAE tube oxygen administration
Secondary ID [1] 282716 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Obesity 289434 0
Desaturation during laryngoscopy (anaesthesia) 289435 0
Condition category
Condition code
Anaesthesiology 289763 289763 0 0
Anaesthetics
Respiratory 289793 289793 0 0
Other respiratory disorders / diseases

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
In theatre patients will receive a standardised induction of anesthesia . For the the laryngoscopy (procedure to visualise the vocal cords and therefore entrance into the windpipe) and intubation (placement of the endotracheal tube into the windpipe) in the anaesthetised and apnoeic patient, the oxygen administration is traditionally interrupted for a short time until the breathing tube is connected to the ventilator. In this study the patients are either receiving additional oxygen (10 l/min flow) via a 3.5 mm RAE tube in the buccal space during laryngascopy or no additional oxygen. During artificially prolonged laryngoscopy the saturation will be recorded for a maximum of 10 min or until the saturation starts to drop to 95%. The patient will then be intubated and anaesthesia will be continued as per routine.

Intervention code [1] 287377 0
Prevention
Intervention code [2] 287402 0
Treatment: Other
Comparator / control treatment
Oxygen 10 l/min versus no flow
Control group
Active

Outcomes
Primary outcome [1] 289848 0
Desaturation (SpO2 to 95%) monitored with pulse oximetry
Timepoint [1] 289848 0
Time to reach SpO2 95% in seconds or 10 min if no desaturation occurs
Secondary outcome [1] 303376 0
NIL
Timepoint [1] 303376 0
NIL

Eligibility
Key inclusion criteria
1) Adult patients requiring general anaesthesia with endotrachel intubation for scheduled surgery
2) BMI 30-40
3) ASA1-2
4) Agree to and capapble of understanding and signing the consent form
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Study population - Exclusion criteria:
1) Age < 18
2) Chronic Respiratory Disease
3 ) SpO2 <98% despite preoxygenation with 100% O2
4) History of difficult intubation or anticipated difficult intubation
5) Uncontrolled hypertension
6) Ischaemic Heart disease or congestive Heart Failure
7) Increased intracranial pressure
7) Gastroesophageal reflux disease
8) Non fasting patients
9) Emergency procedures

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
sealed opaque envelopes
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
computerised sequence generation
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
A power analysis was performed to determine the number of subjects required for the study.
We expected a minimum of 60 seconds difference between the SpO2>95% times of the two groups. Based on this assumption and Type I and Type II errors of 5% and 20%, respectively(power 80%), 15 patients per group were required to prove the hypothesis.
To account for withdrawasls and fall-outs n=20 will be recruited for each group.
All continuous data were identified as nonparameteric and the Mann Whitney U test was used to determine statistical significance between groups. Pearson's chi-squared test and Fisher's exact test will be used to show significant differences between the two groups in frequency data. Statistical analysis(SPSS15.0 for Windows Software) will be used to perform the statistical analysis.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
27/06/2013
Actual
Date of last participant enrolment
Anticipated
20/06/2014
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
40
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
WA
Recruitment hospital [1] 1147 0
Royal Perth Hospital - Perth
Recruitment postcode(s) [1] 6994 0
6847 - Perth

Funding & Sponsors
Funding source category [1] 287487 0
Self funded/Unfunded
Name [1] 287487 0
Country [1] 287487 0
Primary sponsor type
Hospital
Name
Department of Anaesthesia, Royal Perth Hospital
Address
Wellington Street Campus
BOX X2213, GPO
Perth 6847
Western Australia
Country
Australia
Secondary sponsor category [1] 286227 0
None
Name [1] 286227 0
Address [1] 286227 0
Country [1] 286227 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 289463 0
Human Research Ethics Committee
Ethics committee address [1] 289463 0
Ethics committee country [1] 289463 0
Australia
Date submitted for ethics approval [1] 289463 0
Approval date [1] 289463 0
13/06/2013
Ethics approval number [1] 289463 0
REG 13-050

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 40958 0
Dr Andrew Heard
Address 40958 0
Department of Anaesthesia and Pain Medicine
Royal Perth Hospital
Wellington Street Campus
BOX X2213, GPO, Perth 6487
Western Australia
Country 40958 0
Australia
Phone 40958 0
+61 8 92241037
Fax 40958 0
+61 8 92241111
Email 40958 0
[email protected]
Contact person for public queries
Name 40959 0
Andrew Heard
Address 40959 0
Department of Anaesthesia and Pain Medicine
Royal Perth Hospital
Wellington Street Campus
BOX X2213, GPO, Perth 6487
Western Australia
Country 40959 0
Australia
Phone 40959 0
+61 8 92241037
Fax 40959 0
+61 8 92241111
Email 40959 0
[email protected]
Contact person for scientific queries
Name 40960 0
Andrew Heard
Address 40960 0
Department of Anaesthesia and Pain Medicine
Royal Perth Hospital
Wellington Street Campus
BOX X2213, GPO, Perth 6487
Western Australia
Country 40960 0
Australia
Phone 40960 0
+61 8 92241037
Fax 40960 0
+61 8 92241111
Email 40960 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
EmbaseApneic oxygenation during prolonged laryngoscopy in obese patients: A randomized, controlled trial of buccal RAE tube oxygen administration.2017https://dx.doi.org/10.1213/ANE.0000000000001564
N.B. These documents automatically identified may not have been verified by the study sponsor.